Brigid Makes
CIK 1375927 · Chief Financial Officer · last filed 2026-06-15
Brigid Makes is a Chief Financial Officer who has filed 35 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ELUT, was dated Jun 15, 2026. Across all open-market trades the lifetime net is +$35.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $60.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$60.0K
7
35
$35.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 27,000 | $0.92 | $24.7K | $13.0K | 4 | 2026-06-15 |
| QSI | Director | 20,512 | $0.76 | $15.6K | $0 | 6 | 2026-05-20 |
| VANI | Chief Financial Officer | 15,000 | $1.31 | $19.6K | $14.9K | 9 | 2025-05-14 |
| ELUTIA INC. (AZYO) Delisted | Director | 2,000 | $1.49 | $3.0K | $7.3K | 5 | 2023-06-12 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Director | 10,580 | $15.00 | $158.7K | $0 | 3 | 2022-06-06 |
| AGA Medical Holdings, Inc. (AGAM) Delisted | CFO | 0 | — | — | $0 | 2 | 2010-11-18 |
| BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted | Director | 26,000 | — | — | $0 | 4 | 2008-06-16 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | QSI | Grant (A) | — | $0 | EDGAR |
| 2025-12-18 | ELUT | Buy (P) | +25,000 | $13.0K | EDGAR |
| 2025-06-02 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2025-05-21 | QSI | Grant (A) | — | $0 | EDGAR |
| 2025-05-14 | VANI | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | QSI | Grant (A) | — | $0 | EDGAR |
| 2024-05-14 | VANI | Grant (A) | — | $0 | EDGAR |
| 2023-12-18 | VANI | Buy (P) | +5,000 | $4.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.